Deep Vein Thrombosis Dvt clinical trials

Explore recruiting deep vein thrombosis dvt clinical trials.

Recruiting deep vein thrombosis dvt studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Deep Vein Thrombosis Dvt trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Avoiding Risks of Thrombosis and bleeding in Surgery (ARTS): an international randomised controlled trial evaluating apixaban versus no anticoagulation in patients undergoing general abdominal, gynecologic and urologic surgery

Finland

Therapeutic use (Phase IV) EU CTIS Study details

Colchicine to Quench the Inflammatory Response after Deep Vein Thrombosis: The CONQUER-DVT Randomized Controlled Trial

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3, Multicenter, Double-Blinded, Randomized Study to Evaluate REGN7508, a Factor XI Monoclonal Antibody, Versus Acetylsalicylic Acid for Prophylaxis of Symptomatic Venous Thromboembolism After Elective Total Knee Arthroplasty (ROXI-ASPEN)

Greece, Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Clinical Surveillance vs. Anticoagulation for Low-risk Patients with Isolated Subsegmental Pulmonary Embolism: A Multicenter Randomized Placebo-Controlled Non-Inferiority Trial

Netherlands, France, Belgium

Therapeutic use (Phase IV) EU CTIS Study details

API-AHAI - Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess Efficacy and Safety of REGN7508, a Monoclonal Antibody Against FXI, for Primary Prophylaxis of Cancer-Associated Thrombosis for Participants with Solid Tumors Undergoing Cancer Treatment (ROXI-CAT-I)

Belgium, Czechia, France, Romania, Germany, Poland +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Deep Vein Thrombosis Dvt trials by city

Deep Vein Thrombosis Dvt in Toronto Deep Vein Thrombosis Dvt in Vancouver Deep Vein Thrombosis Dvt in Montreal Deep Vein Thrombosis Dvt in Calgary Deep Vein Thrombosis Dvt in Edmonton Deep Vein Thrombosis Dvt in Ottawa Deep Vein Thrombosis Dvt in Winnipeg Deep Vein Thrombosis Dvt in Quebec City Deep Vein Thrombosis Dvt in Hamilton Deep Vein Thrombosis Dvt in Kitchener Deep Vein Thrombosis Dvt in London Deep Vein Thrombosis Dvt in Halifax Deep Vein Thrombosis Dvt in New York Deep Vein Thrombosis Dvt in Los Angeles Deep Vein Thrombosis Dvt in Chicago Deep Vein Thrombosis Dvt in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease